GPX4 and neoplasm: Both in vitro and in vivo results demonstrated that the Mn-S1N3/SAE significantly enhanced catalytic activity within the tumor microenvironment (TME), triggered tumor ferroptosis via LPO accumulation and GPX4 inactivation, which achieved greater tumor suppression than the Mn-N4/SAE analogue.